Trugrace Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 9.00 M
- Company Age 2 Year, 24 Days
- Open Charges ₹ 2.20 Cr
About Trugrace Pharmaceuticals
Trugrace Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2023 (Two years 24 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹2.20 Cr.
Jigarkumar Patel, Jugal Patel, Prafulkumar Patel, and One other member serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15209GJ2023PTC138195
- Company No.
138195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Trugrace Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigarkumar Patel  | Director | 06-Jan-2023 | Current |
| Jugal Patel | Director | 06-Jan-2023 | Current |
| Prafulkumar Patel | Director | 06-Jan-2023 | Current |
| Akash Patel | Additional Director | 02-Dec-2023 | Current |
Financial Performance of Trugrace Pharmaceuticals.
Enhance accessibility to Trugrace Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Trugrace Pharmaceuticals?
Unlock access to Trugrace Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹22.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | State Bank Of India | ₹2.20 Cr | Open |
How Many Employees Work at Trugrace Pharmaceuticals?
Trugrace Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trugrace Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trugrace Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
